Follow
Tim Liebner
Tim Liebner
Postdoctoral Researcher, Novo Nordisk Center for Protein Research University of Copenhagen
Verified email at cpr.ku.dk
Title
Cited by
Cited by
Year
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
T Narita, S Ito, Y Higashijima, WK Chu, K Neumann, J Walter, S Satpathy, ...
Molecular cell 81 (10), 2166-2182. e6, 2021
1582021
Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes
T Narita, Y Higashijima, S Kilic, T Liebner, J Walter, C Choudhary
Nature Genetics 55 (4), 679-692, 2023
392023
HDAC6 modulates myofibril stiffness and diastolic function of the heart
YH Lin, JL Major, T Liebner, Z Hourani, JG Travers, SA Wennersten, ...
The Journal of clinical investigation 132 (10), 2022
312022
A unique H2B acetylation signature marks active enhancers and predicts their target genes
T Narita, Y Higashijima, S Kilic, T Liebner, J Walter, C Choudhary
bioRxiv, 2022.07. 18.500459, 2022
72022
Acetylation of histones and non-histone proteins is not a mere consequence of ongoing transcription
T Liebner, S Kilic, J Walter, H Aibara, T Narita, C Choudhary
Nature Communications 15 (1), 4962, 2024
52024
Histone deacetylase inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells
L Chen, A Zutz, J Phillippou-Massier, T Liebner, OT Keppler, ...
bioRxiv, 2020.04. 29.067884, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–6